Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Merad, Miriam, Martin, Jerome C.·2020·Nature Reviews Immunology
DOI 10.1038/s41577-020-0331-4

Cited by (1,002)

Items 201–300 of 1,002

  1. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
    Laurence K. Albiges, Stéphanie Foulon, Arnaud Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, Annabelle Stoclin, Mansouria Merad-Boudia, Frank Griscelli, Ludovic Lacroix et al. · 2020 · Nature Cancer
  2. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
    Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne K. Cordes, Wolfram Puppe, Günter Bernhardt, Inga Ravens, Christiane Ritter, Christian R Schultze-Florey, Nina Gödecke et al. · 2020 · Cellular and Molecular Immunology
  3. SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
    Juan Ma, Fangrui Zhu, Fei Shao, Fei Shao, Dou Yu, Jiangwen Ma, Xusheng Zhang, Weitao Li, Yan Qian, Yan Zhang et al. · 2021 · The EMBO Journal
  4. Single-cell immunology of SARS-CoV-2 infection
    Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, Michael A. Zager, Evan William Newell, Raphaël Gottardo · 2021 · Nature Biotechnology
  5. Nutrition in the Actual COVID-19 Pandemic. A Narrative Review
    Vicente Javier Clemente‐Suárez, Domingo Jesús Ramos‐Campo, Juan Mielgo‐Ayuso, Athanasios A. Dalamitros, Pantelis Τ. Nikolaidis, Alberto J. Hormeño-Holgado, José Francisco Tornero-Aguilera · 2021 · Nutrients
  6. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study
    Hui Zhang, Chaolin Huang, Xiaoying Gu, Yeming Wang, Xia Li, Min Liu, Qiongya Wang, Jiuyang Xu, Yimin Wang, Huaping Dai et al. · 2023 · The Lancet Respiratory Medicine
  7. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
    Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, Kyle R. Kays, Mayra Pinilla-Vera, Maura E. Benson, MGH COVID-19 Collection & Processing Team et al. · 2021 · Science Translational Medicine
  8. Monocyte activation in systemic Covid-19 infection: Assay and rationale
    Fernando O. Martínez, Theo Combes, Federica Orsenigo, Siamon Gordon · 2020 · EBioMedicine
  9. An Antioxidant Enzyme Therapeutic for COVID‐19
    Meng Qin, Zheng Cao, Jing Wen, Qingsong Yu, Chaoyong Liu, Fang Wang, Jianjun Zhang, Fengmei Yang, Yanyan Li, Gregory A. Fishbein et al. · 2020 · Advanced Materials
  10. Coronavirus Disease 2019–Associated Coagulopathy
    Giuseppe Lippi, Fabián Sanchis‐Gomar, Emmanuel J. Favaloro, Carl J. Lavie, Brandon Michael Henry · 2020 · Mayo Clinic Proceedings
  11. Immune dysregulation and system pathology in COVID-19
    Muhammad Jamal, Hina Iqbal Bangash, Maria Habiba, Yufei Lei, Tian Xie, Jiaxing Sun, Zimeng Wei, Zixi Hong, Liang Shao, Qiuping Zhang · 2021 · Virulence
  12. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
    Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire Paul Millet · 2020 · iScience
  13. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
    Simon Gebremeskel, Julia Schanin, Krysta Mila Coyle, Melina Butuci, Thuy T. Luu, Emily C. Brock, Alan Xu, Alan Wong, John Leung, Wouter Korver et al. · 2021 · Frontiers in Immunology
  14. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy
    Aurelia Magdalena Pisoschi, Aneta Pop, Florin Iordache, Loredana Stanca, Ovidiu Ionuț Geicu, Liviu Bîlteanu, Andreea Iren Șerban · 2022 · European Journal of Medicinal Chemistry
  15. Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
    Qian‐Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yuanwei Pan, Jialin Lai, Yangtao Xu, Zhiqiang Xu, Min Li, Guangyu Zhao et al. · 2023 · Science Advances
  16. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
    Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, Zaki A. Sherif, Christian Bime, Erin Burke Quinlan, Michael A. Portman, Maria Laura Gennaro, Jalees Rehman, RECOVER Mechanistic Pathways Task Force · 2023 · eLife
  17. Hematologic disorders associated with COVID-19: a review
    Mandeep Singh Rahi, Vishal Jindal, SANDRA L PATRUCCO REYES, Kulothungan Gunasekaran, Ruby Gupta, Ishmael A. Jaiyesimi · 2021 · Annals of Hematology
  18. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection
    Rosa, Bruce A., Ahmed, Mushtaq, Singh, Dhiraj K., Choreño-Parra, José Alberto, Cole, Journey, Jiménez-Álvarez, Luis Armando, Rodríguez-Reyna, Tatiana Sofía, Singh, Bindu, Gonzalez, Olga, Carrion, Ricardo et al. · 2021 · Communications Biology
  19. Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
    Yunfeng Zheng, Renfeng Li, Shunai Liu · 2020 · Journal of Medical Virology
  20. TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis
    Thierry Gauthier, Chen Yao, Tyrone Dowdy, Wenwen Jin, Yun-Ji Lim, Liliana Catherine Patiño, Na Liu, Shannon I. Ohlemacher, Andrew Bynum, Rida Kazmi et al. · 2023 · Science Signaling
  21. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
    Robert W. Malone, Philip Tisdall, Philip Fremont‐Smith, Yongfeng Liu, Xi‐Ping Huang, Kris M. White, Lisa Miorin, Elena Moreno, Assaf Alon, Elise Delaforge et al. · 2021 · Frontiers in Pharmacology
  22. Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets
    Justina Kulikauskaite, Andreas Wack · 2020 · Trends in Immunology
  23. A systematic and comprehensive review on current understanding of the pharmacological actions, molecular mechanisms, and clinical implications of the genus Eucalyptus
    Nikhil Chandorkar, Srushti M. Tambe, Purnima Dhanraj Amin, Chandu S. Madankar · 2021 · Phytomedicine Plus
  24. Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
    Zhongwen Li, Shuaishuai Niu, Baojie Guo, Tingting Gao, Lei Wang, Yukai Wang, Liu Wang, Yuanqing Tan, Jun Wu, Jie Hao · 2020 · Cell Proliferation
  25. Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo
    Subramanian, Sethuraman, Busch, Clara Jana-Lui, Molawi, Kaaweh, Geirsdottir, Laufey, Maurizio, Julien, Vargas Aguilar, Stephanie, Belahbib, Hassiba, Gimenez, Gregory, Yuda, Ridzky Anis Advent, Burkon, Michaela et al. · 2022 · Nature Immunology
  26. Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
    Artur Słomka, Mariusz Kowalewski, Ewa Żekanowska · 2020 · Pathogens
  27. Prophetic Medicine-Nigella Sativa (Black cumin seeds) – Potential herb for COVID-19?
    Naina Mohamed Pakkir Maideen · 2020 · Journal of pharmacopuncture
  28. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia
    Zelalem Temesgen, Mariam Assi, Fnu Shweta, Paschalis I. Vergidis, Stacey A. Rizza, Philippe R. Bauer, Brian W. Pickering, Raymund Rabe Razonable, Claudia R. Libertin, Charles D. Burger et al. · 2020 · Mayo Clinic Proceedings
  29. Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
    Calum T. Robb, Marie Goepp, Adriano Giorgio Rossi, Chengcan Yao · 2020 · British Journal of Pharmacology
  30. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
    Stefanie Kreutmair, Susanne Unger, Nicolás Gonzalo Núñez, Florian Ingelfinger, Chiara Alberti, Donatella De Feo, Sinduya Krishnarajah, Manuel Kauffmann, Ekaterina Friebel, Sepideh Babaei et al. · 2021 · Immunity
  31. SARS‐CoV‐2 infection and multi-organ system damage: A review
    Ali Ahmed Rabaan, Samira Smajlović, Hüseyin Tombuloğlu, Sabahudin Ćordić, Azra Hajdarević, Nudžejma Kudić, Abbas Al Mutai, Safaa Abdulrahman Turkistani, Shamsah H. Al-Ahmed, Nisreen A. Al-Zaki et al. · 2022 · Biomolecules and Biomedicine
  32. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors
    Chao Gao, Junwei Zeng, Nan Jia, Kathrin Stavenhagen, Yasuyuki Matsumoto, Hua Zhang, Li Jiang, Adam J. Hume, Elke Mühlberger, Irma van Die et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
    Gabriel Pasquarelli-do-Nascimento, Heloísa Antoniella Braz-de-Melo, Sara Socorro Faria, Igor de Oliveira Santos, Gary Kobinger, Kelly Grace Magalhães · 2020 · Frontiers in Endocrinology
  34. Serum S100B protein as a marker of severity in Covid-19 patients
    Antonio Aceti, Lory Marika Margarucci, Elena Scaramucci, Massimiliano Orsini, Gerardo Salerno, Gabriele Di Sante, Gianluca Gianfranceschi, Rosa Di Liddo, Federica Valeriani, Francesco Ria et al. · 2020 · Scientific Reports
  35. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
    Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, Dylan Postmus, Daria Vladimirova, Julia Kazmierski, Fabian Pott, Kristina Dietert, Michael Mülleder, Vadim M. Farztdinov et al. · 2021 · Nature Communications
  36. SARS-CoV-2 productively infects human brain microvascular endothelial cells
    Ruicheng Yang, Kun Lun Huang, Hui-Peng Zhang, Liang Li, Yufei Zhang, Chen Tan, Huanchun Chen, Meilin Jin, Xiangru Wang, Xiangru Wang · 2022 · Journal of Neuroinflammation
  37. CXCR2 chemokine receptor – a master regulator in cancer and physiology
    Gwendal Lazennec, Krishna Rajarathnam, Ann J. Richmond · 2023 · Trends in Molecular Medicine
  38. Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies
    Claudio Doglioni, Claudia Ravaglia, Marco Chilosi, Giulio Rossi, Alessandra Dubini, Federica Pedica, Sara Piciucchi, Antonio Vizzuso, Franco Stella, Stefano Maitan et al. · 2021 · Respiration
  39. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Ken R. Walder, Michael Berk, LISA S. OLIVE, Andre Ferrer Carvalho et al. · 2021 · Cytokine
  40. Resolvin T-series reduce neutrophil extracellular traps
    Nan Chiang, Miyuki Sakuma, Ana R. Rodrı́guez, Bernd Werner Spur, Daniel Irimia, Charles Nicholas Serhan · 2021 · Blood
  41. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production
    James W. Swann, Oakley C. Olson, Emmanuelle A. Passegue · 2024 · Nature reviews. Immunology
  42. The cytokine storm and thyroid hormone changes in COVID-19
    Laura Croce, Dave Gangemi, G. Ancona, Federico Liboà, Giulia Bendotti, L. Minelli, L. Chiovato · 2021 · Journal of Endocrinological Investigation
  43. Links between Infections, Lung Cancer, and the Immune System
    Liviuţa Budişan, Oana Zănoagă, Cornelia Braicu, Radu Pîrlog, Bogdan Florin Covaliu, Victor Eşanu, Schuyler Safi Korban, Ioana Berindan‐Neagoe · 2021 · International Journal of Molecular Sciences
  44. Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19)
    Júlio César Garcia de Alencar, Claudia de Lucena Moreira, Alicia Dudy Müller Veiga, Cleuber Esteves Chaves, Marina Akemi Fukuhara, Elizabeth Aparecida da Silva, Maria de Fátima Silva Miyamoto, Vanusa Barbosa Pinto, Cauê Gasparotto Bueno, Felippe Lazar Neto et al. · 2020 · Clinical Infectious Diseases
  45. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients
    Silvia Lucena Lage, Eduardo P. Amaral, Kerry L. Hilligan, Elizabeth Laidlaw, Adam W. Rupert, Sivaranjani Namasivayan, Joseph M. Rocco, Frances Galindo, Anela Kellogg, Princy N. Kumar et al. · 2022 · Frontiers in Immunology
  46. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi · 2022 · International Immunopharmacology
  47. Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling
    Haocheng Zhang, Jingwen Ai, Wenjiao Yang, Xian Zhou, Fusheng He, Shumei Xie, Weiqi Zeng, Yang Li, Yiqi Yu, Xuejing Gou et al. · 2020 · Clinical Infectious Diseases
  48. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
    Gang Xu, Ying Li, Shengyuan Zhang, Haoran Peng, Yunyun Wang, Dekang Li, Taijie Jin, Zhuohao He, Yilun Tong, Chunting Qi et al. · 2021 · Cell Research
  49. The role of senescent T cells in immunopathology
    Covre, Luciana P., De Maeyer, Roel P. H., Gomes, Daniel C. O., Akbar, Arne N. · 2020 · Aging Cell
  50. Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
    Abdolreza Esmaeilzadeh, Reza Elahi · 2020 · Journal of Cellular Physiology
  51. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
    Sree Pooja Varahachalam, Behnaz Lahooti, Masoumeh Chamaneh, Sounak Bagchi, Tanya Chhibber, Kevin Morris, Joe F. Bolanos, Nam‐Young Kim, Ajeet Kumar Kaushik · 2021 · International Journal of Nanomedicine
  52. Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset
    Élie Azoulay, Muriel sarah Fartoukh, Michaël Darmon, Guillaume Géri, Guillaume Voiriot, Thibault Dupont, Lara Zafrani, Lola Girodias, Vincent Labbé, Martin Dres et al. · 2020 · Intensive Care Medicine
  53. COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces
    Mehdi Karimi‐Shahri, Hamid Reza Niazkar, Fariba Rad · 2020 · International Journal of Laboratory Hematology
  54. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
    Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, Razieh Forghaniesfidvajani, Monireh Kamali, Azadeh Afzalnia, Shirin Manshouri, Fatemeh Heidari, Majid Pornour, Majid Khoshmirsafa et al. · 2022 · Cellular & Molecular Biology Letters
  55. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
    Ana Muñoz-Jurado, Begoña M. Escribano, Javier Caballero‐Villarraso, Alberto Galván, Eduardo Agüera, Abel Santamarı́a, Isaac Túnez · 2022 · Inflammopharmacology
  56. Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
    Juan García‐Revilla, Tomas Deierborg, Jose Luis Venero, Antonio Boza‐Serrano · 2020 · Frontiers in Immunology
  57. Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020
    Sereina Annik Herzog, Jessie De Bie, Steven Abrams, Ine Wouters, Esra Ekinci, Lisbeth Patteet, Astrid Coppens, Sandy De Spiegeleer, Philippe Beutels, Pierre Van Damme et al. · 2022 · Eurosurveillance
  58. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems
    Emanuela Barisione, Federica Grillo, Lorenzo Ball, Rita Bianchi, Marco Grosso, Patrizia Morbini, Paolo P. Pelosi, Nicolo’ Antonino Patroniti, Arduino De Lucia, Giovanni Orengo et al. · 2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  59. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells
    K. Meyer, T. Patra, Vijayamahantesh, R. Ray · 2021 · Journal of Virology
  60. Biological ageing with HIV infection: evaluating the geroscience hypothesis
    Monty A Montano, Krisann K. Oursler, Ke Xu, Yan V. Sun, Vincent C. Marconi · 2022 · The Lancet Healthy Longevity
  61. Obesity is a potential risk factor contributing to clinical manifestations of COVID-19
    Zhenyu Kang, Shanshan Luo, Gui Yang, Haifeng Zhou, Zili Zhang, Chunxia Tian, Qiaoli Zhou, Quansheng Wang, Yu Hu, Heng Fan et al. · 2020 · International Journal of Obesity
  62. Large‐scale genome sampling reveals unique immunity and metabolic adaptations in bats
    Diana D. Moreno-Santillán, Tanya M. Lama, Yocelyn T. Gutiérrez‐Guerrero, Alexis M. Brown, Paul Donat, Huabin Zhao, Stephen J. Rossiter, Laurel R. Yohe, Joshua H T Potter, Emma C. Teeling et al. · 2021 · Molecular Ecology
  63. COVID-19: Inflammatory Profile
    Yuhang Wang, Stanley M. Perlman · 2021 · Annual Review of Medicine
  64. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
    Ceri Alan Fielding, Pragati Sabberwal, James C. Williamson, Edward J. D. Greenwood, Thomas W. M. Crozier, Wioleta Milena Zelek, Jeffrey Seow, Carl Graham, Isabella Huettner, Jonathan D. Edgeworth et al. · 2022 · eLife
  65. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives
    Rosaria Maddalena Ruggeri, Alfredo Campennì, Désirèe Deandreis, Massimiliano Siracusa, Renato Tozzoli, Petra Petranović Ovčariček, Luca Giovanella · 2021 · Expert Review of Clinical Immunology
  66. Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review
    Anson Jose, Shagun Singh, Ajoy Roychoudhury, Yathin Kholakiya, Saurabh Arya, Sunanda Roychoudhury · 2021 · Journal of Maxillofacial and Oral Surgery
  67. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein
    Tianyang Li, Yang Yang, Yongqi Li, Zhengmin Wang, Faxiang Ma, Runqi Luo, Xiaoming Xu, Guo Feng Zhou, Jianhua Wang, Junqi Niu et al. · 2021 · Journal of Clinical Investigation
  68. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
    Benjamin L. Sievers, M. Cheng, Kata Csiba, Bo Meng, Ravindra K. Gupta · 2023 · Cellular & Molecular Immunology
  69. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
    Zilan Wang, Yanbo Yang, Xiaolong Liang, Bixi Gao, Meirong Liu, Wen Li, Zhouqing Chen, Zhong Wang · 2020 · Frontiers in Neurology
  70. Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients
    Marisol Zuniga, Cláudia Gomes, Steven E. Carsons, Michael T. Bender, Paolo Cotzia, Qing Miao, David C. Lee, Ana Rodrı́guez · 2021 · European Respiratory Journal
  71. Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
    Umberto Pensato, Lorenzo Muccioli, Ilaria Cani, Damir Janigro, Pier Luigi Zinzani, Maria Guarino, Pietro Cortelli, Francesca Bisulli · 2021 · Annals of Clinical and Translational Neurology
  72. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital
    Emanuele Cereda, Laura Bogliolo, Catherine Klersy, Federica Lobascio, Sara Masi, Silvia Crotti, Ludovico De Stefano, Raffaele Bruno, Angelo Guido Corsico, Antonio Di Sabatino et al. · 2020 · Clinical Nutrition
  73. Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
    Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, Carlos P. Roca, Margaux Gerbaux, Silke Janssens, Mathijs Willemsen, Oliver T. Burton, Pierre Van Mol, Yannick Van Herck et al. · 2020 · Clinical & Translational Immunology
  74. Haemophagocytic syndrome and COVID-19
    Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, M.J. Soto Cárdenas, Manuel Ramos‐Casals · 2021 · Clinical Rheumatology
  75. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
    Vincent J. Venditto, Dalia Haydar, Ahmed Abdel‐Latif, John C. Gensel, Michael Anstead, Michelle G. Pitts, Jarrod W. Creameans, Timothy Joseph Kopper, Chi Peng, David J. Feola · 2021 · Frontiers in Immunology
  76. COVID-19 Impairs Immune Response to Candida albicans
    Dominique Moser, Katharina Biere, Bing Han, Marion Hoerl, Gustav Schelling, Alexander Choukèr, Tobias Woehrle · 2021 · Frontiers in Immunology
  77. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury
    Mengli Wu, Feng‐Liang Liu, Jing Sun, Xin Li, Xiao-Yan He, Hong‐Yi Zheng, Rongjuan Pei, Hao Sun, Yan-Heng Zhou, Qihong Yan et al. · 2021 · Signal Transduction and Targeted Therapy
  78. Association between Microorganisms and Microplastics: How Does It Change the Host–Pathogen Interaction and Subsequent Immune Response?
    Wenjie Yang, Yang Li, Diana Boraschi · 2023 · International Journal of Molecular Sciences
  79. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study
    Sébastien Tanaka, Christian de Tymowski, Maksud Assadi, Nathalie Zappella, Sylvain Jean‐Baptiste, Tiphaine Robert, Katell Peoc’h, Brice Lortat‐Jacob, Lauriane Fontaine, Donia Bouzid et al. · 2020 · PLoS ONE
  80. Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study
    Isabel María Cornejo-Pareja, Isabel María Vegas-Aguilar, José Manuel García‐Almeida, Diego Bellido, Antonio Talluri, Henry C. Lukaski, Francisco José Tinahones · 2021 · Clinical Nutrition
  81. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model
    Q. Lian, Kui-Hua Zhang, Zhao Zhang, Fu-Yu Duan, Li-Yan Guo, Wei-Ren Luo, Bo-Bo W. Mok, A. Thakur, Xiaoshan Ke, Pedram Motallebnejad et al. · 2022 · Nature Communications
  82. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
    Lorenzo Maria Canziani, Serena Trovati, Enrico Brunetta, Amidio Testa, Maria De Santis, Emilio Bombardieri, Giacomo Maria Guidelli, Giovanni Albano, Marco Folci, Michela Squadroni et al. · 2020 · Journal of Autoimmunity
  83. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts
    Liuliu Yang, Yuling Han, Fabrice Jaffré, Benjamin E. Nilsson-Payant, Yaron Bram, Pengfei Wang, Jiajun Zhu, Tuo Zhang, David Redmond, Sean Houghton et al. · 2021 · Circulation Research
  84. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
    Peiran Chen, Mandi Wu, Yaqing He, Bing‐Hua Jiang, Ming‐Liang He · 2023 · Signal Transduction and Targeted Therapy
  85. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
    Nicolas Huot, Cyril Planchais, Pierre Rosenbaum, Vanessa Contreras, Béatrice Jacquelin, Caroline Petitdemange, Marie Lazzerini, Emma Beaumont, Aurelio Orta Resendiz, Felix Augusto Rey et al. · 2023 · Nature Immunology
  86. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
    Julio Villena, Haruki Kitazawa · 2020 · Frontiers in Physiology
  87. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
    Anno Saris, Tom D. Y. Reijnders, Esther J. Nossent, Alex R. Schuurman, Jan Verhoeff, Saskia D. van Asten, Hetty J. Bontkes, Siebe G. Blok, JanWillem Duitman, Harm Jan Bogaard et al. · 2021 · Thorax
  88. Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
    Stefan F. H. Neys, Rudi W. Hendriks, Odilia B. J. Corneth · 2021 · Frontiers in Cell and Developmental Biology
  89. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
    Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, Jhimli Banerjee, Biplab Giri, Sandeep Kumar Dash · 2022 · Immunologic Research
  90. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
    Christoph Schultheiß, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Lidia Bosurgi, Jochen Dutzmann, Daniel Sedding, Thomas Frese, Matthias Girndt et al. · 2022 · Journal of Medical Virology
  91. The role of cell death in SARS-CoV-2 infection
    Cui Yuan, Zhenling Ma, Jiufeng Xie, Wenqing Li, Lijuan Su, Guozhi Zhang, Jun Chen Xu, Yaru Wu, Min Zhang, Wei Liu · 2023 · Signal Transduction and Targeted Therapy
  92. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
    E. Campione, C. Lanna, Terenzio Cosio, Luigi Rosa, M. Conte, F. Iacovelli, Alice Romeo, M. Falconi, C. Del Vecchio, E. Franchin et al. · 2021 · International Journal of Environmental Research and Public Health
  93. Clinical trial to test the efficacy of melatonin in COVID‐19
    Darı́o Acuña-Castroviejo, Germaine Escames, Juan Carlos Figueira, Pedro de la Oliva, Alberto Manuel Borobia, Carlos Acuña‐Fernández · 2020 · Journal of Pineal Research
  94. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
    Didier M. Payen, Maxime Cravat, Hadil Maadadi, Carole Didelot, Lydia Prosic, Claire Dupuis, Marie-Reine Losser, Marcelo De Carvalho Bittencourt · 2020 · Frontiers in Immunology
  95. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α
    Paolo Frisoni, Margherita Neri, Stefano D’Errico, Letizia Alfieri, Diana Bonuccelli, Mariano Cingolani, Marco Di Paolo, Rosa Maria Gaudio, Maurizio Lestani, Matteo Marti et al. · 2021 · Forensic Science Medicine and Pathology
  96. Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19
    Adalberto Fernandes Dos Santos, Pedro Manuel Sarmento Rodrigues Póvoa, Paulo Paixão, António Mendonça, Luís Taborda‐Barata · 2021 · Frontiers in Chemistry
  97. Hematopoietic responses to SARS-CoV-2 infection
    Shokrollah Elahi · 2022 · Cellular and Molecular Life Sciences
  98. Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?
    Noemí Güemes-Villahoz, Barbara Burgos‐Blasco, Ana Arribi Vilela, Pedro Arriola‐Villalobos, Carla Rico-Luna, Ricardo Cuiña‐Sardiña, Alberto Delgado‐Iribarren, Julián García‐Feijoó · 2020 · Journal of Medical Virology
  99. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration?
    Michael J. Young, Méabh O’Hare, Marcelo Matiello, Jeremy Dan Schmahmann · 2020 · Brain Behavior and Immunity
  100. COVID-19 Therapeutic Options Under Investigation
    Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Hussein Eid, Hassan Zaraket · 2020 · Frontiers in Pharmacology